Form 4: Adagio Medical Holdings Director James L. Cox Reports Acquisition of 36,698 Shares in Business Combination

Director James L. Cox reports acquisition of 36,698 shares of Adagio Medical Holdings, Inc. common stock following a business combination.

Summary

• On July 31, 2024, James L. Cox, a director of Adagio Medical Holdings, Inc., acquired 36,698 shares of common stock.
• This acquisition was a result of the business combination between Adagio Medical Holdings, Inc. (formerly Aja Holdco Inc.) and ARYA Sciences Acquisition Corp IV, Adagio Medical, Inc., and other parties.
• The business combination agreement (BCA) was dated February 13, 2024.
• The Registration Statement on Form S-4 (File No. 333-278811) related to the business combination was declared effective on July 12, 2024.
• The shares were acquired in exchange for shares of Adagio common stock held by Mr. Cox prior to the completion of the Business Combination.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing related to a business combination and a director's share acquisition. There's no inherent positive or negative implication.

Positives

• A director's increased stake in the company can be seen as a positive sign of confidence in the company's future.

Industry Context

This announcement reflects a common corporate action where a business combination leads to changes in share ownership among key stakeholders, such as directors. It's typical for directors to receive shares as part of such transactions.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder confidence due to a director increasing their stake in the company.

Key Dates